Entity Details

Primary name THYG_HUMAN
Entity type UniProt
Source Source Link

Details

AccessionP01266
EntryNameTHYG_HUMAN
FullNameThyroglobulin
TaxID9606
Evidenceevidence at protein level
Length2768
SequenceStatuscomplete
DateCreated1986-07-21
DateModified2021-06-02

Ontological Relatives

GenesTG

GO terms

Show/Hide Table
GOName
GO:0005179 hormone activity
GO:0005576 extracellular region
GO:0005615 extracellular space
GO:0006590 thyroid hormone generation
GO:0007165 signal transduction
GO:0015705 iodide transport
GO:0030878 thyroid gland development
GO:0031641 regulation of myelination
GO:0042446 hormone biosynthetic process
GO:0042802 identical protein binding

Subcellular Location

Show/Hide Table
Subcellular Location
Secreted

Domains

Show/Hide Table
DomainNameCategoryType
IPR000716 Thyroglobulin type-1DomainDomain
IPR002018 Carboxylesterase, type BDomainDomain
IPR011641 Tyrosine-protein kinase ephrin type A/B receptor-likeDomainDomain
IPR016324 ThyroglobulinFamilyFamily
IPR019819 Carboxylesterase type B, conserved siteSiteConserved site
IPR029058 Alpha/Beta hydrolase foldFamilyHomologous superfamily
IPR036857 Thyroglobulin type-1 superfamilyFamilyHomologous superfamily

Diseases

Show/Hide Table
Disease IDSourceNameDescription
274700 OMIMThyroid dyshormonogenesis 3 (TDH3)A disorder due to thyroid dyshormonogenesis, causing large goiters of elastic and soft consistency in the majority of patients. Although the degree of thyroid dysfunction varies considerably among patients with defective thyroglobulin synthesis, patients usually have a relatively high serum free triiodothyronine (T3) concentration with disproportionately low free tetraiodothyronine (T4) level. The maintenance of relatively high free T3 levels prevents profound tissue hypothyroidism except in brain and pituitary, which are dependent on T4 supply, resulting in neurologic and intellectual defects in some cases. The disease is caused by variants affecting the gene represented in this entry.
608175 OMIMAutoimmune thyroid disease 3 (AITD3)A complex autoimmune disorder comprising two related diseases affecting the thyroid: Graves disease and Hashimoto thyroiditis. In both disorders, thyroid-reactive T-cells are formed and infiltrate the thyroid gland. In Graves disease, the majority of the T-cells undergo a Th2 differentiation and activate B-cells to produce antibodies against the TSH receptor, which stimulate the thyroid and cause clinical hyperthyroidism. In contrast, Hashimoto thyroiditis is characterized by Th1 switching of the thyroid-infiltrating T-cells, which induces apoptosis of thyroid follicular cells and clinical hypothyroidism. Disease susceptibility is associated with variants affecting the gene represented in this entry.

Drugs

Show/Hide Table
DrugNameSourceType
DB05382 IodineDrugbanksmall molecule